Randomized placebo Controlled Trial comparing the efficacy of rectal diclofenac, EMLA with a placebo in pain control for hysterosalpingography (HSG).
Not Applicable
- Conditions
- Fertility-female
- Registration Number
- PACTR201904530885595
- Lead Sponsor
- ational Hospital Abuja
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
1.All women between the ages of 18 and 49 years undergoing hysterosalpingography as part of their infertility work-up at National Hospital Abuja during the study period.
2.Women already investigated and/or treated for PID.
3.Women with no cervical stenosis or congenital uterine anomaly
Exclusion Criteria
1.Non consenting patients.
2.Patients with active pelvic inflammatory disease
3.Patients with history of any allergy to radiopaque dye, local anaesthetics or anti-inflammatory medications.
4.Patients with previous cervical surgery.
5.Patients younger than 18 years or older than 49 years.
6.Patient who took any form of analgesic within 48 hours before presentation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be the differences in mean pain scores during the procedure in the three groups.
- Secondary Outcome Measures
Name Time Method The differences in pain scores at 30minutes and 24 hours after the procedure, level of satisfaction and side effects